EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

An integrative transcriptomic analysis for prognosis and tumor microenvironment in HBV/HCV-associated hepatocellular carcinoma

Fahimeh Safarnezhad Tameshkel, Niloufar Sadat Kalaki, Elham Karimi, Mohammad Hossein Razizadeh, Abed El Hasan Haidar, Ali Amiri, Mohammadreza Zaki, Mehdi Nikkhah, Mohammad Hadi Karbalaie Niya

Molecular Therapy Oncology · 2026-06 · 34 (2) · 201218

DOI: 10.1016/j.omton.2026.201218 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy Oncology, 2026-06. Verfasst von Fahimeh Safarnezhad Tameshkel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Iran University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality worldwide; molecular biomarkers that reflect hepatitis B virus (HBV)/hepatitis C virus (HCV)-associated tumor biology and predict prognosis or therapeutic vulnerabilities are needed. The research is a secondary analysis of public data (secondary data analysis) based on Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) data to identify differentially expressed genes (DEGs) common to HBV-HCC, HCV-HCC, and non-viral HCC datasets. Gene Ontology (GO)/Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment, protein-protein interaction (PPI) network analysis, and hub-gene selection were then performed. Differential expression, prognostic association, immune-infiltration, and drug-sensitivity correlations were also analyzed. Eighty common DEGs (73 upregulated, 7 downregulated) were identified. PPI topological analysis yielded 53 hub genes; five genes TOP2A, RACGAP1, ASPM, CENPF, and GPC3, were prioritized and validated as significantly upregulated in liver HCC and associated with poorer overall survival. Immune deconvolution showed consistent positive correlations between the hub genes and B cells and regulatory T cell subsets, and negative correlations with mucosal-associated invariant T (MAIT) cells, macrophages, and natural killer (NK)/monocyte signatures. Drug-gene correlation analysis revealed positive associations of TOP2A and RACGAP1 with sensitivity to mitogen-activated protein kinase inhibitors and negative correlations with several targeted inhibitors. The identified prognostically unfavorable hub genes in HBV/HCV-associated HCC are associated with an immunosuppressive microenvironment and with patterns of drug sensitivity.

Schlagwörter

Stichwörter der Autor:innen

DEGsPPI networkbioinformaticsdifferentially expressed geneshepatocellular carcinomahub genemolecular biomarkerprognosisprotein-protein interaction networktarget-specific therapiestranscriptomic analysistumor biologviral hepatitis

Autor:innen und Institutionen

  • Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Student Research Commitee, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Centre for Phage Research, Department of Genetics and Genome Biology, University of Leicester, Leicester, UK.

Förderung

  • Iran University of Medical Sciences

Zitieren

APA

Safarnezhad Tameshkel, F., Sadat Kalaki, N., Karimi, E., Razizadeh, M. H., Haidar, A. E. H., Amiri, A., Zaki, M., Nikkhah, M., & Karbalaie Niya, M. H. (2026). An integrative transcriptomic analysis for prognosis and tumor microenvironment in HBV/HCV-associated hepatocellular carcinoma. Molecular Therapy Oncology, 34(2), 201218. https://doi.org/10.1016/j.omton.2026.201218

Vancouver

Safarnezhad Tameshkel F, Sadat Kalaki N, Karimi E, Razizadeh MH, Haidar AEH, Amiri A, et al. An integrative transcriptomic analysis for prognosis and tumor microenvironment in HBV/HCV-associated hepatocellular carcinoma. Molecular Therapy Oncology. 2026;34(2):201218. doi:10.1016/j.omton.2026.201218

BibTeX
@article{SafarnezhadTameshkel2026,
  author = {Safarnezhad Tameshkel, Fahimeh and Sadat Kalaki, Niloufar and Karimi, Elham and Razizadeh, Mohammad Hossein and Haidar, Abed El Hasan and Amiri, Ali and Zaki, Mohammadreza and Nikkhah, Mehdi and Karbalaie Niya, Mohammad Hadi},
  title = {An integrative transcriptomic analysis for prognosis and tumor microenvironment in HBV/HCV-associated hepatocellular carcinoma},
  journal = {Molecular Therapy Oncology},
  year = {2026},
  volume = {34},
  number = {2},
  pages = {201218},
  doi = {10.1016/j.omton.2026.201218}
}
Kostenlos starten →